The prognostic relevance of examined lymph nodes for accurate staging of resected pancreatic adenocarcinoma  

作　　者：Claudia Zaharia Marcus Roalsø Kjetil Søreide 

机构地区：[1]Department of Pathology,Stavanger University Hospital,Stavanger,Norway [2]Department of Gastrointestinal Surgery,HPB Unit,Stavanger University Hospital,Stavanger,Norway [3]Department of Quality and Health Technology,University of Stavanger,Stavanger,Norway [4]Department of Clinical Medicine,University of Bergen,Bergen,Norway

出　　处：《Hepatobiliary Surgery and Nutrition》2022年第4期632-635,共4页肝胆外科与营养（英文）

摘　　要：Pancreatic ductal adenocarcinoma(PDAC)is a disease with a particular aggressive cancer biology and,unfortunately,a very poor prognosis for most patients.There is no question about the lethality of pancreatic cancer.However,the question why this malignancy is so deadly remains a biological puzzle both to investigators and caretakers alike.Staging of pancreatic cancer undergoing resection-while important to compare cohorts across studies and trials-also allows for a clinical clue about the progress of the disease.

关 键 词：ADENOCARCINOMA cancer PROGNOSIS 

分 类 号：R735.9[医药卫生—肿瘤]